Literature DB >> 23605255

Expression of VEGF and collagen XVIII in meningiomas: correlations with histopathological and MRI characteristics.

Niina Salokorpi1, Sanna Yrjänä, Hannu Tuominen, Ari Karttunen, Ritva Heljasvaara, Taina Pihlajaniemi, Esa Heikkinen, John Koivukangas.   

Abstract

BACKGROUND: The objective of this study was to assess the possibility of predicting histological characteristics of meningiomas on the basis of preoperative MRI and the correlation of the expression of vascular endothelial growth factor (VEGF) and collagen XVIII with histological parameters already established as predictive of the course of these tumors.
METHODS: Expression of VEGF and collagen XVIII as well as other histological characteristics was examined in meningioma tissues from 20 patients. Preoperative MRI, including dynamic imaging of contrast enhancement, was analyzed. Times to maximum enhancement and maximum intensity increase were noted from dynamic imaging. The relative intensity of the tumor in fluid-attenuated inversion recovery (FLAIR), T2-weighted and contrast enhanced T1-weighted images, as well as volumes of tumor and edema, was calculated. The edema-tumor volume ratio was defined as the edema index (EI).
RESULTS: Both VEGF and collagen XVIII were expressed in all meningioma samples. Edema was present in 60 % of cases. The strongest correlation of VEGF expression was to EI. Among histological parameters, microvessel density (MVD) and cellularity correlated moderately with VEGF. Collagen XVIII expression correlated strongly with the maximal intensity increase after contrast agent administration (ρ = 0.71, P = 0.001) as well as with MVD and intensity of the meningioma on FLAIR images.
CONCLUSION: Meningiomas with faster and more intense enhancement in dynamic studies, indicative of good tumor blood supply and permeability of vasculature, are associated with high levels of collagen XVIII and VEGF expression. Occurrence of peritumoral edema in meningiomas is strongly correlated with expression of VEGF.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23605255     DOI: 10.1007/s00701-013-1699-8

Source DB:  PubMed          Journal:  Acta Neurochir (Wien)        ISSN: 0001-6268            Impact factor:   2.216


  5 in total

Review 1.  Pathogenesis of peri-tumoral edema in intracranial meningiomas.

Authors:  Moncef Berhouma; Timothee Jacquesson; Emmanuel Jouanneau; François Cotton
Journal:  Neurosurg Rev       Date:  2017-08-24       Impact factor: 3.042

2.  Peritumoral edema correlates with mutational burden in meningiomas.

Authors:  Corey M Gill; Joshua Loewenstern; John W Rutland; Hanane Arib; Margaret Pain; Melissa Umphlett; Yayoi Kinoshita; Russell B McBride; Joshua Bederson; Michael Donovan; Robert Sebra; Mary Fowkes; Raj K Shrivastava
Journal:  Neuroradiology       Date:  2020-08-12       Impact factor: 2.804

3.  Expression of MMP-9 and VEGF in meningiomas and their correlation with peritumoral brain edema.

Authors:  Joanna Reszec; Adam Hermanowicz; Robert Rutkowski; Grzegorz Turek; Zenon Mariak; Lech Chyczewski
Journal:  Biomed Res Int       Date:  2015-03-03       Impact factor: 3.411

4.  Efficacy of Bevacizumab in High-Grade Meningiomas: A Retrospective Clinical Study.

Authors:  Xuexue Bai; Xiaomin Liu; Jun Wen
Journal:  Neuropsychiatr Dis Treat       Date:  2022-08-06       Impact factor: 2.989

5.  The relationship between vascular endothelial growth factor and histological grade in intracranial meningioma.

Authors:  Rafael Contage Winter; Apio Claudio Martins Antunes; Francine Hehn de Oliveira
Journal:  Surg Neurol Int       Date:  2020-10-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.